Search Results 451-460 of 18880 for Neutrophil

1. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

   Participation eligibility · Hemoglobin ≥9.0 g/dL · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelet count ≥100,000/mm3 · Creatinine ≤1.5 x ULN OR measured ...

2. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/μL;; Platelet count ≥100,000/μL;; Hemoglobin ≥8.0 g/dL;; Serum total bilirubin ≤1.5 x upper limit of normal (ULN) or ...

3. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,500 /mcL. ANC: ______ Date of Test: ______. Platelet count ≥ 100,000 /mcL. Platelet:______ Date of Test: ______.

4. A Study to Evaluate Trifluridine/Tipiracil in Combination with Irinotecan to Treat Biliary Tract Cancers - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm3;; Platelet count ≥ 100,000/mm3;; Total bilirubin ≤ 1.5 × upper limit of normal (ULN);; spartate transaminase (AST) ...

5. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 1500 cells/mm3; Platelet count ≥ 100,000 plts/mm3 (without transfusion); ≥ 75,000 plts/mm3 for patients with ...

6. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/mm^3;; Platelet count 100,000/mm^3;; Total bilirubin ≤ 1.5 upper limit of normal (ULN), or if total bilirubin is > 1.5 ...

7. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

   An absolute neutrophil count of < 1000 cells/µL during Screening. Known or suspected current (< 90 days) illicit drug use. Note: marijuana use is allowed ...

8. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm3; Platelet count ≥ 75,000/mm3; Hemoglobin ≥ 9.0 g/dL; Creatinine ≤ 2 x ULN; SGOT (AST) ≤ 2 x ULN; Albumin ≥ 3 g ...

9. Testing The Role Of DNA Released From Tumor Cells Into The Blood In Guiding The Use Of Immunotherapy After Surgical Removal Of The Bladder, Kidney, Ureter, And Urethra For Urothelial Cancer Treatment, MODERN Study - Mayo Clinic

   PRE-REGISTRATION: Absolute Neutrophil Count (ANC) >= 1,200/mm^3. PRE-REGISTRATION: Platelet count >= 100,000/mm^3. PRE-REGISTRATION: Hemoglobin >= 8 g/dL. PRE ...

10. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

    Absolute neutrophil count (ANC) <1,000/μL (1.0 X 109/L); Platelet count <50,000/μL (50 X 109/L); Serum aspartate aminotransferase (AST)/serum glutamic ...